首页> 外文OA文献 >First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses

【2h】

First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses

机译：新型脂质防病毒缀合物CMX001中的一种药代动力学和安全性研究，一种抗双链DNA病毒的广谱口腔药物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wendy Painter; Alice Robertson; Lawrence C. Trost; Susan Godkin; Bernhard Lampert; George Painter;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review [J] . Chemaly Roy F., Hill Joshua A., Voigt Sebastian, Antiviral Research . 2019,第期

机译：目前可用和调查抗病毒药对致病性人双链DNA病毒的体外比较：系统文献综述
2. Antiviral Activity, Safety, and Pharmacokinetics of AL-794, a Novel Oral Influenza Endonuclease Inhibitor: Results of an Influenza Human Challenge Study [J] . Yogaratnam Jeysen, Rito Jennifer, Kakuda Thomas N., The Journal of Infectious Diseases . 2019,第2期

机译：Al-794的抗病毒活性，安全和药代动力学，一种新型口服流感内切核酸酶抑制剂：流感人类挑战研究的结果
3. First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma [J] . Massard Christophe, Soria Jean-Charles, Krauss Juergen, Cancer chemotherapy and pharmacology. . 2019,第6期

机译：在复发/难治性肾细胞癌患者中评估抗CD27L抗体 - 药物缀合物AMG 172的安全性，耐受性，药代动力学和药效动物的第一人体研究
4. An LC-MS/MS Assay for Simultaneous Quantitation of Docetaxel and its Prodrug-Conjugate for Pharmacokinetic Studies of PRINT-Lipidized-Docetaxel Nanoparticles in Mice [C] . Allison N. Schorzman, Kevin S. Chu, Matt Finniss, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：用于同时定量多西紫杉醇的LC-MS / MS测定，用于小鼠的印刷 - 脂质化 - 多西紫杉醇纳米粒子的药代动力学研究
5. Integration of preclinical and clinical data with pharmacokinetic modeling and simulations to characterize the disposition of orally-active antiparasitic prodrugs and metabolites: Prediction of the dose-exposure relationship in humans. [D] . Yan, Zhixia. 2011

机译：临床前和临床数据与药代动力学建模和模拟的集成，以表征口服活性抗寄生虫前药和代谢物的分布：预测人类的剂量-暴露关系。
6. First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001 a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses [O] . Wendy Painter, Alice Robertson, Lawrence C. Trost, 2012

机译：新型脂质抗病毒缀合物CMX001（一种对双链DNA病毒具有活性的广谱口服药物）在人体中的首次药代动力学和安全性研究
7. Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2 [O] . Wendy P. Painter, Wayne Holman, Jim A. Bush, 2021

机译：Molnupiravir的人性安全性，耐受性和药代动力学，一种新型广谱口腔抗病毒试剂，具有针对SARS-COV-2的活性

First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses

著录项

引文网络

相似文献

相关主题

期刊订阅